Skip to main content
. Author manuscript; available in PMC: 2014 Aug 11.
Published in final edited form as: Lancet. 2013 Dec 6;383(9929):1677–1687. doi: 10.1016/S0140-6736(13)62036-X
Dopaminergic index Link to schizophrenia Strength of evidence
Drug studies Effect of DA agonist drugs
(eg amphetamine)
Induces/ worsens psychotic symptoms +
Effect of DA receptor antagonists
(eg antipsychotics)
Reduces symptoms ++
Effect of DA depleting drugs
(eg reserpine)
Reduces symptoms +
Peripheral markers DA metabolites in CSF and plasma Increased in schizophrenia ~
may depend on phase of illness and influenced by peripheral catecholamine metabolism
Ex vivo studies Dopamine and DA metabolite levels in brain Increased in striatum in schizophrenia +
potentially confounded by prior antipsychotic treatment
Brain imaging studies DA synthesis and DA release capacity, and baseline DA levels Increased in striatum in schizophrenia ++

++=found in meta-analysis; += found in well-controlled studies; ~inconsistent findings